LUKAS WILLIAMS: Open Payments
NPI 1265065619 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$414 in 17 payments from 7 companies in 2025. Trend: 2023 $440 · 2024 $50 · 2025 $414
Food & beverage: $414
| Company | Payments | Amount |
|---|---|---|
| Optinose US, Inc. | 5 | $126 |
| ALK-Abello, Inc | 4 | $101 |
| GENZYME CORPORATION | 2 | $66 |
| Paratek Pharmaceuticals, Inc. | 2 | $40 |
| Novartis Pharmaceuticals Corporation | 2 | $33 |
| AstraZeneca Pharmaceuticals LP | 1 | $27 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
Products named: Xhance, DUPIXENT, NEFFY, TEZSPIRE, TIMOTHY, STANDARDIZED, Rhapsido.
Industry payments across DC — which companies pay providers there.
